IMARC Group, a leading market research company, has recently releases report titled “EPA DHA Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,” The study provides a detailed analysis of the industry, including the global EPA DHA market share, size, trends, and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the EPA DHA market?
The global EPA DHA market size reached US$ 1,877.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,228.8 Million by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032.
Factors Affecting the Growth of the EPA DHA Industry:
- Increasing consumer awareness of health benefits:
Both EPA and DHA are essential omega-3 fatty acids that have been widely considered for their beneficial effects on cardiovascular health, cognitive function, and inflammatory responses. As scientific research continues to highlight the health benefits of these fatty acids, consumers are becoming more informed about the importance of incorporating EPA and DHA into their diets. For instance, studies have shown that EPA and DHA can reduce the risk of heart disease, support brain health, and alleviate symptoms of inflammatory conditions such as arthritis. This growing awareness is leading consumers to seek out products enriched with EPA and DHA, contributing to the expansion of the market.
- Rising demand for functional foods and dietary supplements:
As people become more focused on preventive healthcare and maintaining overall well-being, there is a growing interest in functional foods and dietary supplements that offer added health benefits beyond basic nutrition. EPA and DHA are commonly found in fish oil supplements, fortified foods, and beverages, which are marketed as supporting heart health, brain function, and general vitality. The popularity of dietary supplements and fortified foods that contain EPA and DHA is driven by the desire for convenient ways to enhance nutritional intake and address specific health concerns. This trend is evident in the increasing number of functional food products and supplement formulations that highlight EPA and DHA as key ingredients, further bolstering the market growth.
- Advancements in production technologies:
Advancements in production technologies are driving the growth of the EPA and DHA market by improving the quality, bioavailability, and sustainability of these fatty acids. Innovations in extraction and purification processes have led to the development of high-quality, concentrated forms of EPA and DHA that are more effective and easier to incorporate into various products. Additionally, advancements in sustainable sourcing practices, such as the use of algae-based omega-3s, address environmental concerns associated with traditional fish oil production. These technological improvements enhance the efficacy and appeal of EPA and DHA supplements and support the industry's growth by meeting consumer demand for high-quality, sustainably sourced products, supporting the market growth.
Request for a sample copy of this report: https://www.imarcgroup.com/epa-dha-market/requestsample
EPA DHA Market Report Segmentation:
Market Breakup by Type:
- Eicosapentaenoic Acid (EPA)
- Docosahexaenoic Acid (DHA)
Docosahexaenoic Acid (DHA) dominates the market due to its critical role in brain health and development, making it highly sought after for cognitive and neurological benefits.
Market Breakup by Source:
- Fish Oil
- Algae Oil
- Krill Oil
- Others
Fish oil holds the majority of shares because it is a rich and traditional source of both EPA and DHA, widely recognized for its health benefits.
Market Breakup by Application:
- Infant Formulae
- Dietary Supplements
- Fortified Food and Beverages
- Pharmaceuticals
- Others
Dietary supplements account for the majority of shares as consumers increasingly use them to ensure adequate intake of EPA and DHA for cardiovascular and overall health.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Asia Pacific enjoys the leading position due to high fish consumption and growing health awareness leading to increased demand for omega-3 products in countries like Japan, China, and India.
Global EPA DHA Market Trends:
The increasing incorporation of these fatty acids into pet nutrition products, as consumers become more aware of their benefits for animal health, and the rise of personalized nutrition plans that include tailored omega-3 supplements for individual health needs are strengthening the market growth. Apart from this, the expansion of omega-3s into novel applications, such as beauty and skincare products, where they are valued for their anti-inflammatory and skin-rejuvenating properties, and the increasing popularity of personalized wellness programs that integrate omega-3s for targeted health benefits impelling the market growth.
Who are the key players operating in the industry?
The report covers the major market players including:
- Adamis Pharmaceuticals Corporation
- Amneal Pharmaceuticals Inc.
- Antares Pharma Inc
- Bausch Health
- Kaleo Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc
Browse the full report with TOC and list of Figures: https://www.imarcgroup.com/request?type=reportid=7339flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
